secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2021-08-05T23:59:59+00:00
Accession:  0000010795-21-000054
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD beats with Q3 revenue $4.9B (+26.9% YoY), raises FY2021 guidance; CFO to retire
--------------------------------------------------------------------------------

- Q3 revenue $4.9B, up 26.9% reported / 22.0% currency-neutral; GAAP EPS $1.72, adjusted EPS $2.74 (+24.5% YoY).
- Raised FY2021 guidance: reported rev growth 16.5-17.0% (prior 12-14%), currency-neutral ~14.0%, adjusted EPS $12.85-$12.95 (prior $12.75-$12.85).
- COVID-19 testing revenue $300M; repurchased 4.1M shares for $1.0B at avg $242/share.
- CFO Christopher Reidy (EVP, CFO, CAO) intends to retire; will remain until external successor found; will join board of planned Diabetes Care spinoff (NewCo) expected H1 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000001079521000054/0000010795-21-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000001079521000054/bdx-20210802.htm
  HTML page:      https://secwatch.observer/filing/0000010795-21-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer